{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:50:12Z","timestamp":1747288212743},"reference-count":36,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2024,5,31]]},"DOI":"10.7883\/yoken.jjid.2023.211","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T22:13:12Z","timestamp":1703715192000},"page":"129-136","source":"Crossref","is-referenced-by-count":1,"title":["Dysregulated Leukotriene Metabolism in Patients with COVID-19"],"prefix":"10.7883","volume":"77","author":[{"given":"Halef Okan","family":"Do\u011fan","sequence":"first","affiliation":[{"name":"Department of Biochemistry, School of Medicine, Sivas Cumhuriyet University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahir","family":"Budak","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Faculty of Science, Sivas Cumhuriyet University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00fcbra","family":"Do\u011fan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Sivas Numune Hospital, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6zde Ert\u00fcrk","family":"Zarars\u0131z","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Medicine, Erciyes University, Turkey"},{"name":"Drug Application and Research Center (ERFARMA), Erciyes University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serra \u0130layda","family":"Yerlita\u015f","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Medicine, Erciyes University, Turkey"},{"name":"Drug Application and Research Center (ERFARMA), Erciyes University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"Bolat","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine, Sivas Cumhuriyet University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"\u015eenol","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Atat\u00fcrk University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyit Ali","family":"B\u00fcy\u00fcktuna","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinic Microbiology, School of Medicine, Sivas Cumhuriyet University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ergun","family":"P\u0131narba\u015f\u0131","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, School of Medicine, Sivas Cumhuriyet University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u011f\u0131p","family":"Sar\u0131ismailo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Sivas State Hospital, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayrettin","family":"Yavuz","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, University of Virginia, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gautam S, Setu S, Khan MGQ, et al. Analysis of the health, economic and environmental impacts of COVID-19: the Bangladesh perspective. Geosystems Geoenviron. 2022;1:100011.","DOI":"10.1016\/j.geogeo.2021.100011"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kashte S, Gulbake A, El-Amin Iii SF, et al. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021;34:711-733.","DOI":"10.1007\/s13577-021-00512-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. de Morais Batista F, Puga MAM, da Silva PV, et al. Serum biomarkers associated with SARS-CoV-2 severity. Sci Rep. 2022;12:15999.","DOI":"10.1038\/s41598-022-20062-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the &apos;cytokine storm&apos; in COVID-19. J infect. 2020;80:607-613.","DOI":"10.1016\/j.jinf.2020.03.037"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15:511-523.","DOI":"10.1038\/nri3859"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ghosh A, Chen F, Thakur A, et al. Cysteinyl leukotrienes and their receptors: emerging therapeutic targets in central nervous system disorders. CNS Neurosci Ther. 2016;22:943-951.","DOI":"10.1111\/cns.12596"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors; emerging concepts. Allergy Asthma Immunol Res. 2014;6:288-295.","DOI":"10.4168\/aair.2014.6.4.288"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Murphy RC, Gij\u00f3n MA. Biosynthesis and metabolism of leukotrienes. Biochem J. 2007;405:379-395.","DOI":"10.1042\/BJ20070289"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Peters-Golden M, Henderson WR Jr. Leukotrienes. New Engl J Med. 2007;357:1841-1854.","DOI":"10.1056\/NEJMra071371"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Carobene A, Strollo M, Jonker N, et al. Sample collections from healthy volunteers for biological variation estimates\u2019 update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2016;54:1599-1608.","DOI":"10.1515\/cclm-2016-0035"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods. 2001;25:402-408.","DOI":"10.1006\/meth.2001.1262"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ripon MAR, Bhowmik DR, Amin MT, et al. Role of arachidonic cascade in COVID-19 infection: a review. Prostaglandins Other Lipid Mediat. 2021;154:106539.","DOI":"10.1016\/j.prostaglandins.2021.106539"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Schwarz B, Sharma L, Roberts L, et al. Cutting edge: severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome, resulting in dysregulation of eicosanoid immune mediators. J Immunol. 2021;206:329-334.","DOI":"10.4049\/jimmunol.2001025"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Barberis E, Timo S, Amede E, et al. Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2. Int J Mol Sci. 2020;21:8623.","DOI":"10.3390\/ijms21228623"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Danlos FX, Grajeda-Iglesias C, Durand S, et al. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021;12:258.","DOI":"10.1038\/s41419-021-03540-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bonyek-Silva I, Machado AFA, Cerqueira-Silva T, et al. LTB4-driven inflammation and increased expression of <i>ALOX5\/ACE2<\/i> during severe COVID-19 in individuals with diabetes. Diabetes. 2021;70:2120-30.","DOI":"10.2337\/db20-1260"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Agbuduwe C, Basu S. Haematological manifestations of COVID\u201019: from cytopenia to coagulopathy. Eur J Hepatol. 2020;105:540-546.","DOI":"10.1111\/ejh.13491"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Alzaid F, Julla JB, Diedisheim M, et al. Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID\u201019 in type 2 diabetes. EMBO Mol Med. 2020;12:e13038.","DOI":"10.15252\/emmm.202013038"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Anurag A, Jha PK, Kumar A. Differential white blood cell count in the COVID-19: a cross-sectional study of 148 patients. Diabetes Metab Syndr. 2020;14:2099-2102.","DOI":"10.1016\/j.dsx.2020.10.029"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kilercik M, Demirelce \u00d6, Serdar MA, et al. A new haematocytometric index: predicting severity and mortality risk value in COVID-19 patients. PLoS One. 2021;16:e0254073.","DOI":"10.1371\/journal.pone.0254073"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hedi H, Norbert G. 5-Lipoxygenase pathway, dendritic cells, and adaptive immunity. J Biomed Biotechnol. 2004;2004:99-105.","DOI":"10.1155\/S1110724304310041"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Vaz de Paula CB, de Azevedo MLV, Nagashima S, et al. IL-4\/IL-13 remodeling pathway of COVID-19 lung injury. Sci Rep. 2020;10:18689.","DOI":"10.1038\/s41598-020-75659-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Donlan AN, Sutherland TE, Marie C, et al. IL-13 is a driver of COVID-19 severity. JCI Insight. 2021;6:150107.","DOI":"10.1172\/jci.insight.150107"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Colazzo F, Gelosa P, Tremoli E, et al. Role of the cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases. Mediators inflamm. 2017;2017:2432958.","DOI":"10.1155\/2017\/2432958"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Miyata J, Fukunaga K, Kawashima Y, et al. Cysteinyl leukotriene metabolism of human eosinophils in allergic disease. Allergol Int. 2020;69:28-34.","DOI":"10.1016\/j.alit.2019.06.002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ayola-Serrano NC, Roy N, Fathah Z, et al. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications. Inflamm Res. 2021;70:877-889.","DOI":"10.1007\/s00011-021-01473-y"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Okunishi K, Dohi M, Nakagome K, et al. A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol. 2004;173:6393-6402.","DOI":"10.4049\/jimmunol.173.10.6393"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lone AM, Task\u00e9n K. Proinflammatory and immunoregulatory roles of eicosanoids in T cells. Front Immunol. 2013;4:130.","DOI":"10.3389\/fimmu.2013.00130"},{"key":"29","unstructured":"29. Hojo M, Suzuki M, Maghni K, et al. Role of cysteinyl leukotrienes in CD4<sup>+<\/sup> T cell-driven late allergic airway responses. J Pharmacol Exp Ther. 2000;293:410-416."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20:529-536.","DOI":"10.1038\/s41577-020-0402-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Carey MA, Bradbury JA, Seubert JM, et al. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J Immunol. 2005;175:6878-6884.","DOI":"10.4049\/jimmunol.175.10.6878"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Singh RK, Gupta S, Dastidar S, et al. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology. 2010;85:336-349.","DOI":"10.1159\/000312669"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Khan AR, Misdary C, Yegya-Raman N, et al. Montelukast in hospitalized patients diagnosed with COVID-19. J Asthma. 2022:59:780-786.","DOI":"10.1080\/02770903.2021.1881967"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Do\u011fan HO, \u015eenol O, Bolat S, et al. Understanding the pathophysiological changes via untargeted metabolomics in COVID\u201019 patients. J Med Virol. 2021;93:2340-2349.","DOI":"10.1002\/jmv.26716"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bivona G, Agnello L, Ciaccio M. Biomarkers for prognosis and treatment response in COVID-19 patients. Ann Lab Med. 2021;41:540-548.","DOI":"10.3343\/alm.2021.41.6.540"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2021;26:107-108.","DOI":"10.1136\/bmjebm-2020-111536"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/77\/3\/77_JJID.2023.211\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T04:17:47Z","timestamp":1716610667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/77\/3\/77_JJID.2023.211\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2023.211","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"article-number":"JJID.2023.211"}}